Form 4: Masimo Corp COO Bilal Muhsin Exercises Options and Sells Shares
SEC Form 4 Filing
Bilal Muhsin, Chief Operating Officer of Masimo Corp, exercised stock options and sold shares of common stock on May 12, 2025, according to a Form 4 filing with the SEC.
Summary
- On May 12, 2025, Bilal Muhsin, the Chief Operating Officer of Masimo Corp, exercised non-qualified stock options to acquire 10,000 shares of common stock at a price of $34.51 per share.
- Simultaneously, Muhsin sold 3,881 shares at a weighted average price of $162.719, 5,594 shares at a weighted average price of $163.508, and 525 shares at a weighted average price of $164.962.
- These sales were executed under a pre-arranged Rule 10b5-1 sales plan adopted on December 13, 2024.
- Following these transactions, Muhsin directly owns 24,172 shares of Masimo Corp common stock and holds options to purchase additional shares.
Sentiment
Score: 5
Explanation: The document reflects routine transactions related to executive compensation and pre-planned stock sales, indicating a neutral sentiment.
Industry Context
Executive stock option exercises and sales are a common occurrence in publicly traded companies and are often part of executive compensation packages. The use of a 10b5-1 plan suggests the sales were pre-planned to avoid insider trading concerns.
Comparison to Industry Standards
- Executive compensation practices, including stock options and sales, vary across the medical device industry.
- Companies like Medtronic, Stryker, and Boston Scientific also utilize stock options as part of their executive compensation packages.
- The vesting schedules and exercise prices are typically benchmarked against industry peers to attract and retain talent.
- The use of Rule 10b5-1 plans is a standard practice among executives to manage their stock sales in compliance with insider trading regulations.
Stakeholder Impact
- The stock sales may have a minor impact on the stock price in the short term.
- The transactions do not appear to have a significant impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 05/13/2015 | Date the non-qualified stock option was granted. |
| 05/13/2016 | First date the non-qualified stock option was exercisable. |
| 12/13/2024 | Date of Rule 10b5-1 Sales Plan adoption. |
| 05/12/2025 | Date of stock option exercise and share sales. |
| 05/13/2025 | Expiration date of the non-qualified stock option. |
| 05/14/2025 | Date of Form 4 filing. |
Keywords
Form 4, Masimo Corp, MASI, Bilal Muhsin, Stock Options, Share Sales, Rule 10b5-1, Insider Trading, SEC Filing, COO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.